News Sentiment

RCE sentiment intelligence

Recce Pharmaceuticals Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 20 relevant articles
Exchange ASX Australia
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.39 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

93/100 classification confidence.

Company focus 20

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+2.7% over one week, -23.0% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

ASX Today: Why Recce Pharmaceuticals (ASX:RCE) Shares Are Gaining

Market Reaction

Balanced read

64/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 93/100 classification
One-week reaction 2.7% Price confirming higher
Trend fit Trend inactive -23.0% over four weeks
Fair value -19.8% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 17
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 20
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Kalkine 7
Kalkine Media 2
Moomoo 2
simplywall.st 2
smallcaps.com.au 2
TradingView 1
Stockhead 1
The Australian 1

Event Lens

What the news is about

Classified themes
Market update 19
Earnings 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-20 of 20